Results 101 to 110 of about 329,096 (211)
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherapy was usually delivered with a palliative goal. Stereotactic ablative radiotherapy (SABR) allows the delivery of high doses on small treatment volumes in ...
Rosario Mazzola +17 more
core +2 more sources
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few
Alexander Rühle +3 more
doaj +1 more source
Continuing Professional Development—Radiation Therapy
Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 174-174, March 2025.
wiley +1 more source
Proton beam radiotherapy in the management of uveal melanoma: clinical experience in Scotland [PDF]
<p>Aim: To evaluate proton-beam radiotherapy (PBRT) in the management of uveal melanoma in Scotland.</p> <p>Methods: A retrospective review was undertaken on all patients receiving PBRT for uveal melanoma (1994–2005).
McConnachie, A. +9 more
core +1 more source
Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer
Stereotactic ablative body radiotherapy (SABR) has a role as definitive therapy in many tumor sites; however, its role in the treatment of breast cancer is less well explored.
Aisling Barry, Anthony Fyles
doaj +1 more source
Background. Stereotactic radiotherapy is a non-invasive, ablative technique which may be particularly effective in treating metastatic renal cell carcinoma (RCC).
Farshad Foroudi (804990) +4 more
core +1 more source
Bronchiolitis obliterans organizing pneumonia is an interstitial lung disease rarely occurring after radiotherapy probably due to an activation of autoimmune processes.
D. Alterio +15 more
core +1 more source
Dose Accumulation for Pelvic Stereotactic Ablative Radiotherapy Reirradiation
Despite the increasing use of reirradiation, our understanding of appropriate normal tissue dose constraints remains limited. This is intrinsically tied to major uncertainties concerning evaluation of cumulative doses from multiple treatment courses.
F. Slevin +8 more
openaire +3 more sources
In 2016, surgery is the standard of care for peripheral stage I non-small cell lung cancer. However, recent thought-provoking randomized evidence suggests stereotactic ablative body radiotherapy (SABR) has survival outcomes similar to those of surgery ...
Siva, S, Ball, D
core +1 more source

